Gilman Steven C is a director of Scynexis Inc.
Person profile
Roles
Address
Lexington, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Jun 24 | AKBA Akebia Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 117,130 |
6 Jun 24 | AKBA Akebia Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.07 | 45,000 | 48.15 k | 45,000 |
1 May 24 | VCEL Vericel | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,200 | 0.00 | 11,000 |
1 May 24 | VCEL Vericel | RSU Common Stock | Grant | Acquire A | No | No | 0 | 3,200 | 0.00 | 3,200 |
1 May 24 | VCEL Vericel | Stock Option Common Stock | Grant | Acquire A | No | No | 47.08 | 8,000 | 376.64 k | 8,000 |
1 May 24 | VCEL Vericel | RSU Common Stock | Option exercise | Acquire M | No | No | 0 | 3,200 | 0.00 | 0 |
15 Jun 23 | SCYX Scynexis | Common Stock | Grant | Acquire A | No | No | 0 | 10,000 | 0.00 | 24,000 |
15 Jun 23 | SCYX Scynexis | Stock Option Common Stock | Grant | Acquire A | No | No | 2.74 | 10,000 | 27.40 k | 10,000 |
6 Jun 23 | AKBA Akebia Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 87,130 |
6 Jun 23 | AKBA Akebia Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.2 | 45,000 | 54.00 k | 45,000 |